Table 4.
Prevalence and distribution of different multidrug resistance phenotypes among three serovars isolated
| Serovars | Resistance pattern | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | ||
| S. Infantis | 5 | 3 | 4 | 78 | 17 | 8 | 19 | 5 | 1 | 140 |
| S. Manhattan | – | – | – | 8 | 1 | 1 | 85 | 3 | – | 98 |
| S. Schwarzengrund | – | – | – | 5 | – | – | – | – | – | 5 |
| Total | 5 | 3 | 4 | 91 | 18 | 9 | 104 | 8 | 1 | 243 |
Resistance pattern of 3: SSuT
Resistance pattern of 4: ASSuT
Resistance pattern of 6: ASSuT-CT, CF and ASSuT-CT, CX
S Streptomycin, Su Sulfamethoxazole, T Oxytetracycline, A Ampicillin, CT cefotaxime, CF Ceftiofur, CX Cefoxitin